LOM Asset Management
VRTX icon

LOM Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

LOM Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$818K Hold
1,565
– – 0.21% 110
2026
Q2 		$777K Hold
1,565
– – 0.2% 105
2026
Q1 		$699K Hold
1,565
– – 0.2% 114
2025
Q4 		$710K Hold
1,565
– – 0.21% 112
2025
Q3 		$613K Hold
1,565
– – 0.19% 120
2025
Q2 		$697K Buy
+1,565
New +$721K 0.24% 113

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

LOM Asset Management's VRTX Position: Q3 2026 in Review

LOM Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 1,565 shares worth $818K. The position accounts for 0.21% of the portfolio, ranked #110.

LOM Asset Management first reported a position in VRTX in Q2 2025 and has held it in 6 quarters since. 1,356 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • LOM Asset Management held 1,565 shares of Vertex Pharmaceuticals worth $818K as of Q3 2026.
  • LOM Asset Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.21% of LOM Asset Management's portfolio in Q3 2026, its #110 holding.
  • LOM Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on LOM Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.